Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients (Q46954545)
Jump to navigation
Jump to search
scientific article published in December 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients |
scientific article published in December 2002 |
Statements
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients (English)
Rene Verdonk
Pol Maria Rommens
Shunmugam Govender
Cristina Csimma
Harry K Genant
Alexandre Valentin-Opran
Yehuda Amit
Ron Arbel
Hannu Aro
Dan Atar
Michael Bishay
Martin G Börner
Philippe Chiron
Peter Choong
John Cinats
Brett Courtenay
Robert Feibel
Bernard Geulette
Charles Gravel
Norbert Haas
M Raschke
Eric Hammacher
D van der Velde
Philippe Hardy
Michael Holt
Christof Josten
Rupert Ludwig Ketterl
Bennie Lindeque
GĂ¼nter Lob
Henry Mathevon
Gerald McCoy
D Marsh
Russell Miller
Everard Munting
Stein Oevre
L Nordsletten
Amratlal Patel
Anthony Pohl
William Rennie
Peter Reynders
Jean Rondia
Willem C Rossouw
P J Daneel
Stephen Ruff
Axel RĂ¼ter
Seppo Santavirta
Thomas A Schildhauer
C Gekle
Reinhard Schnettler
David Segal
Hanns Seiler
Robert B Snowdowne
Jouwert Stapert
Gilbert Taglang
Lucas Vogels
Arnulf Weckbach
Andreas Wentzensen
Tadeusz Wisniewski
BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group
1 December 2002
84-A
12
2123-2134